International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 3 | Views: 112 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Research Paper | Ayurveda | India | Volume 11 Issue 3, March 2022


Therapeutic and Safety Aspects of Amrita

Dr. Swati Sharma [4]


Abstract: Amrita (Guduchi) has been used in Ayurvedic preparations for the treatment of various ailments throughout the centuries. It is used as a rasayana to improve the immune system and body resistance against infections. The whole plant is used medicinally; however, the stem is approved for use in medicine as listed by the Ayurvedic Pharmacopoeia of India. The phytoconstituents reported from this herb belong to different classes, such as alkaloids, diterpenoid lactones, glycosides, steroids, phenolics, aliphatic compounds and polysaccharides. Various properties of amrita has been described in ancient texts of Ayurveda, like Rasayana, Sangrahi, Balya, Agnideepana, Tridoshshamaka, Dahnashaka, Mehnashaka, Kasa-swasahara, Pandunashaka, Kamla-Kushta-Vataraktanashaka, Jwarhara, Krimihara, Prameha, Arshnashaka, Kricch-Hridroganashak, etc., are acquiring scientific validity through modern researches. Potential medicinal properties reported by scientific research include anti-diabetic, antipyretic, antispasmodic, anti-inflammatory, anti-arthritic, antioxidant, anti-allergic, anti-stress, anti-leprotic, antimalarial, hepato-protective, immuno-modulatory and anti-neoplastic activities. This review brings together various properties and medicinal uses of amrita described in Ayurvedic classical texts along with phytochemical and pharmacological characters.


Keywords: Anti-leprotic, Balya, Phytoconstituents, Prameha, Rasayana, Tridoshashamaka


Edition: Volume 11 Issue 3, March 2022,


Pages: 211 - 215


How to Download this Article?

Type Your Valid Email Address below to Receive the Article PDF Link


Verification Code will appear in 2 Seconds ... Wait

Top